AllianceBernstein
AGL icon

AllianceBernstein’s Agilon Health AGL Stock Holding History

AllianceBernstein’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Sell
13,103
-1
-0% -$16 ﹤0.01% 3155
2025
Q4 		$226K Sell
13,104
-332
-2% -$6.44K ﹤0.01% 3018
2025
Q3 		$346K Sell
13,436
-22,574
-63% -$853K ﹤0.01% 2872
2025
Q2 		$2.07M Buy
36,010
+5,137
+17% +$412K ﹤0.01% 1914
2025
Q1 		$3.34M Buy
30,873
+15,617
+102% +$1.36M ﹤0.01% 1632
2024
Q4 		$725K Sell
15,256
-3,822
-20% -$231K ﹤0.01% 2484
2024
Q3 		$1.87M Sell
19,078
-17,153
-47% -$2.21M ﹤0.01% 1999
2024
Q2 		$5.92M Buy
36,231
+30,924
+583% +$4.41M ﹤0.01% 1427
2024
Q1 		$809K Buy
5,307
+1,603
+43% +$267K ﹤0.01% 2378
2023
Q4 		$1.16M Buy
3,704
+213
+6% +$77.1K ﹤0.01% 2196
2023
Q3 		$1.55M Sell
3,491
-70
-2% -$31.6K ﹤0.01% 2016
2023
Q2 		$1.54M Buy
3,561
+1,171
+49% +$658K ﹤0.01% 2045
2023
Q1 		$1.42M Sell
2,390
-541
-18% -$303K ﹤0.01% 2061
2022
Q4 		$1.18M Sell
2,931
-1,391
-32% -$652K ﹤0.01% 2194
2022
Q3 		$2.53M Sell
4,322
-129
-3% -$77.2K ﹤0.01% 1733
2022
Q2 		$2.43M Sell
4,451
-247
-5% -$125K ﹤0.01% 1826
2022
Q1 		$2.98M Buy
4,698
+105
+2% +$54.1K ﹤0.01% 1855
2021
Q4 		$3.1M Buy
4,593
+3,387
+281% +$2.06M ﹤0.01% 1884
2021
Q3 		$790K Buy
1,206
+66
+6% +$56.4K ﹤0.01% 2586
2021
Q2 		$1.16M Buy
+1,140
New +$999K ﹤0.01% 2473

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

AllianceBernstein's AGL Position: Q1 2026 in Review

AllianceBernstein reduced its Agilon Health (AGL) stake by 0.01% in Q1 2026, selling an estimated $16 and leaving 13,103 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3155.

AllianceBernstein first reported a position in AGL in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.92M in Q2 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • AllianceBernstein held 13,103 shares of Agilon Health worth $104K as of Q1 2026.
  • AllianceBernstein sold 1 Agilon Health share in Q1 2026, an estimated $16.
  • Agilon Health made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3155 holding.
  • AllianceBernstein first reported a position in Agilon Health in Q2 2021 and has held it in 20 quarters since.
  • AllianceBernstein's Agilon Health position peaked at $5.92M in Q2 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.